000 07051naaaa2201933uu 4500
001 https://directory.doabooks.org/handle/20.500.12854/69023
005 20220714192833.0
020 _abooks978-3-03936-385-8
020 _a9783039363841
020 _a9783039363858
024 7 _a10.3390/books978-3-03936-385-8
_cdoi
041 0 _aEnglish
042 _adc
072 7 _aM
_2bicssc
100 1 _aJavadov, Sabzali
_4edt
_91617948
700 1 _aKozlov, Andrey V.
_4edt
_91617949
700 1 _aCamara, Amadou K.S.
_4edt
_91617950
700 1 _aJavadov, Sabzali
_4oth
_91617948
700 1 _aKozlov, Andrey V.
_4oth
_91617949
700 1 _aCamara, Amadou K.S.
_4oth
_91617950
245 1 0 _aMitochondria in Health and Diseases
260 _aBasel, Switzerland
_bMDPI - Multidisciplinary Digital Publishing Institute
_c2020
300 _a1 electronic resource (434 p.)
506 0 _aOpen Access
_2star
_fUnrestricted online access
520 _aMitochondria are subcellular organelles evolved by the endosymbiosis of bacteria with eukaryotic cells. They are the main source of ATP in the cell and engaged in other aspects of cell metabolism and cell function, including the regulation of ion homeostasis, cell growth, redox status, and cell signaling. Due to their central role in cell life and death, mitochondria are also involved in the pathogenesis and progression of human diseases/conditions, including neurodegenerative and cardiovascular disorders, cancer, diabetes, inflammation, and aging. However, despite the increasing number of studies, precise mechanisms whereby mitochondria are involved in the regulation of basic physiological functions, as well as their role in the cell under pathophysiological conditions, remain unknown. A lack of in-depth knowledge of the regulatory mechanisms of mitochondrial metabolism and function, as well as interplay between the factors that transform the organelle from its role in pro-survival to pro-death, have hindered the development of new mitochondria-targeted pharmacological and conditional approaches for the treatment of human diseases. This book highlights the latest achievements in elucidating the role of mitochondria under physiological conditions, in various cell/animal models of human diseases, and in patients.
540 _aCreative Commons
_fhttps://creativecommons.org/licenses/by/4.0/
_2cc
_4https://creativecommons.org/licenses/by/4.0/
546 _aEnglish
650 7 _aMedicine
_2bicssc
653 _ahypoglycemia
653 _asodium dichloroacetate
653 _apyruvate dehydrogenase kinase
653 _apyruvate dehydrogenase
653 _aoxidative stress
653 _aneuron death
653 _acholangiocellular carcinoma
653 _amitochondria
653 _aenergy metabolism
653 _aoxidative phosphorylation
653 _a4-HNE
653 _aDRP1
653 _aERK1/2
653 _ahippocampus
653 _aJNK
653 _amitochondrial dynamics
653 _aPKA
653 _aprotein phosphatases
653 _aTUNEL
653 _aDDE
653 _ahigh-fat diet
653 _amitochondrial UCP2
653 _aROS
653 _aantioxidant system
653 _auncoupling protein
653 _amitochondria: energy metabolism
653 _alipid handling
653 _afatty acid oxidation
653 _apotassium channel
653 _areactive oxygen species
653 _aantioxidants
653 _alife span
653 _aaging
653 _aBKCa channels
653 _apravastatin
653 _agemfibrozil
653 _aliver
653 _acolon
653 _amitochondrial function
653 _acyclosporin A
653 _amitochondria calcium buffering
653 _amitochondria bioenergetics
653 _amitochondria permeability transition pore
653 _ainorganic phosphate
653 _ahepatic fibrogenesis
653 _aHtrA2/Omi
653 _areactive oxygen species stress
653 _amitochondrial homeostasis
653 _acomplex I (CI) deficiency
653 _ametabolome and proteome profiling
653 _areactive oxygen species (ROS)
653 _arespirasome assembly
653 _aelectron tunneling (ET)
653 _aperilipin 5
653 _alipid droplet
653 _aH9c2 cardiomyoblasts
653 _aadenine nucleotide translocase
653 _arespiratory supercomplexes
653 _aETC complexes
653 _adentate granule cell
653 _aepilepsy
653 _ahyperforin
653 _aLONP1
653 _aneuroprotection
653 _apilocarpine
653 _aseizure
653 _asiRNA
653 _acardioprotection
653 _amitochondrial permeability transition pores
653 _amitochondrial connexin 43
653 _acardiolipin
653 _airon overload
653 _ahepcidin
653 _atransferrin
653 _aferritin
653 _aZIP
653 _ainflammation
653 _amtDNA
653 _amitochondrial dysfunction
653 _amuscle aging
653 _aphysical performance
653 _aLHON
653 _aSiberian population
653 _aancient mutation
653 _aspecific genetic background
653 _aapoptosis
653 _ahuman amniotic membrane
653 _amitochondrial cell death
653 _aBAX
653 _aBCL-2
653 _atensile strength
653 _amitochondrial gene expression
653 _amtDNA transcription
653 _amtRNA
653 _apost-transcriptional mtRNA processing
653 _adsRNA
653 _ainnate immunity
653 _ainterferon response
653 _aamino acid neurotransmitter
653 _acerebellar amino acid metabolism
653 _ahypoxia
653 _a2-oxoglutarate dehydrogenase
653 _atricarboxylic acid cycle
653 _aheart
653 _acytoskeletal proteins
653 _amitochondrial interactions
653 _aplectin
653 _atubulin beta
653 _asignaling
653 _aGW9662
653 _aischemia reperfusion injury
653 _aLangendorff
653 _amyocardial
653 _apioglitazone
653 _aredox state
653 _arosiglitazone
653 _aTZD
653 _auncoupling
653 _aADP/ATP carrier
653 _aKmADP
653 _adextran
653 _amorphology
653 _acardiomyocytes
653 _atelomere length
653 _atelomerase activity
653 _adevelopment
653 _aregeneration
653 _aintranuclear mitochondria
653 _ahealthy cells
653 _aelectron and confocal microscopy
653 _asignaling pathways
653 _aion homeostasis
653 _ahuman diseases
856 4 0 _awww.oapen.org
_uhttps://mdpi.com/books/pdfview/book/2792
_70
_zDOAB: download the publication
856 4 0 _awww.oapen.org
_uhttps://directory.doabooks.org/handle/20.500.12854/69023
_70
_zDOAB: description of the publication
999 _c3016719
_d3016719